In a clinical study of 103 people, 70% of people treated with Acthar Gel had improvement in symptoms at 1 week, compared with 49% of people treated with an inactive injection.
In the same study, 65% of people treated with Acthar Gel showed improvements in disability at week 4, compared with 48% of people treated with inactive injection.
Side effects were seen in 43.7% of people taking Acthar Gel compared with 8.5% of people treated with an inactive injection. The most common side effects of Acthar Gel were acne, unwanted hair growth, and moon face.
Optic neuritis* and MS attacks
In a clinical study of 50 people with relapsing MS, those treated for optic neuritis with active therapy showed a quicker and more complete recovery from MS vision problems. At 30 days, 92% of people treated with active therapy showed improvement compared with 52% of people treated with an inactive injection.
*Optic neuritis is inflammation that damages the optic nerve, a bundle of nerve fibers that transmits visual information from your eye to your brain. Pain and temporary vision loss in one eye are common symptoms.
Learn more about Acthar Gel